DRUG UTILISATION PATTERN IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN A TERTIARY CARE TEACHING HOSPITAL
|
|
- Willis Paul Wilcox
- 5 years ago
- Views:
Transcription
1 Page6258 Indo American Journal of Pharmaceutical Research, 2016 ISSN NO: DRUG UTILISATION PATTERN IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN A TERTIARY CARE TEACHING HOSPITAL Vikneswari 1,2, T. Tamizh Mani *1 1 Bharathi College of Pharmacy, Bharathi Nagar, Mandya, Karnataka, India. 2 Faculty of Pharmacy, PG studies, Pacific University, Udaipur, Rajasthan, India. ARTICLE INFO Article history Received 26/07/2016 Available online 04/08/2016 Keywords COPD, Drug Utilization, Inhalational Therapy. ABSTRACT Chronic Respiratory Diseases (CRD) such as Chronic Obstructive Pulmonary Disease (COPD) may account for an estimated burden of about 100 million individuals in India. The technique of drug utilization review (DUR) can provide useful means of determining whether drug use is as appropriate in treatment of individual patients. This was a Prospective study with the aim of analyse the drug prescribing pattern in Chronic obstructivepulmonary disease patients and the prescribing parameters in the collected prescription. The study has been conducted on male and female patients who were satisfying the inclusion criteria. A suitably designed case record form was prepared and used to record all the necessary and relevant data from the medical records of patients. A total of 250 patients were analysed in our study. Out of that 188 were males and 62 were females. The prescription of more than 3 drugs for one patient may be attributed to the possibility of some patients presenting with acute and chronic exacerbation of COPD with or without co-morbid conditions, which requires antibiotic and corticosteroid treatment. Antibiotics were mostly prescribed (19.2%), followed by anticholinergics (18.70%). Inhalation route (38.32%) was more preferred over parenteral (37.98%) and oral route (23.70%). In our study, we observed that the incidence of COPD was more common in males when compared to females. The majority of patients have intermittent exacerbations of COPD due to the inadequate pattern of drug use. GOLD guidelines can be properly followed for prescribing drugs for COPD and can be achieve total control of COPD. Corresponding author Dr. T. Tamizh Mani Principal and Professor Bharathi College of Pharmacy Bharathi Nagar, Mandya Karnataka, India avikneswari11@gmail.com, ttmani@rediffmail.com Please cite this article in press as Dr. T. Tamizh Mani et al. Drug Utilisation Pattern in Chronic Obstructive Pulmonary Disease in a Tertiary Care Teaching Hospital. Indo American Journal of Pharmaceutical Research.2016:6(07). Copy right 2016 This is an Open Access article distributed under the terms of the Indo American journal of Pharmaceutical Research, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2 Page6259 INTRODUCTION Chronic Obstructive Pulmonary Disease (COPD) has been a major public health problem during this century, and will remain a challenge for the future. Worldwide COPD is in spotlight, because of its high prevalence, morbidity and mortality create powerful challenges for healthcare systems [1]. The global prevalence of COPD in adults aged >40years was approximately 9-10 per cent and the overall prevalence of Chronic Bronchitis in adults >35years alone was 3.49%. COPD may develop due to multiple factors and the risk factors can be genetic or environmental [2]. In chronic respiratory disease like COPD, it becomes very essential to create awareness among the patients about medication and disease. The technique Of Drug Utilization Review (DUR) can provide useful means of determining whether drug use is as appropriate in treatment of individual patients. According to World Health Organization (WHO), drug utilisation can be defined as the marketing, distribution, prescription and use of drugs in a society emphasising its medical, social, and economic consequences [3]. DUR can be used for the description of drug use pattern; early signals of irrational use of drugs; interventions to improve drug use; quality control cycle; continuous quality improvement [4]. Bad prescribing habits lead to ineffective and unsafe treatment, exacerbation or prolongation of illness, distress and harm to the patient and higher costs. Monitoring of prescriptions and drug utilization studies can identify the problems and provide feedback to prescribers so as to create awareness about irrational use of drugs [5]. The practice of DUE is usually applied by the pharmacist to check the appropriateness of drugs prescribed, as a prescription is considered to be an abstract of physician understands of disease and management through drugs. Apart from the rational use of drug, DUE can play an important role in assisting the physician s prescribing attitude in accordance with the predetermined standards by allocating them with the feed-back. This information may also helpful in improvising the prescribing and dispensing practices by designing, conducting and imparting educational programmes for healthcare providers. Hence Drug utilization studies provide useful insights into current prescribing practices an can thus help in reforming and updating practices in clinical medicine and pharmacotherapy [6]. COPD is usually under diagnosed and under treated. Hence it is the fifth cause of morbidity and mortality in the developed world [7]. All COPD patients with breathlessness when walking at their own pace on level ground appear to benefit from rehabilitation and maintenance of physical activity. An exacerbation of COPD is an acute event characterized by a worsening of the patient s respiratory symptoms that is beyond normal day-to-day variations and leads to a change in medication. COPD often coexists with other diseases (co morbidities) that may have a significant impact on prognosis [8].The respiratory condition of the subjects was improved upon prescribed with an antibiotic for 3-5 days [ 9]. Hence the present study has planned to evaluate the utilization of the medications that were prescribed for treating the patients with COPD in tertiary care teaching hospital. MATERIALS AND METHOD A prospective, observational study was planned with aim to evaluate drug utilizing pattern in COPD in MIMS teaching hospital and research centre. The study was conducted in the general medicine department for 6 month duration, after getting approval from the institutional ethics committee of MIMS teaching hospital. The patients were recruited based on the inclusion and exclusion criteria. Inclusion criteria: The subjects included in this study were both sex and aged above 40 years and above, who have been diagnosed with COPD with or without comorbidities and admitted in the general medicine ward during the study period. Exclusion criteria: 1. All patients who has undergone cardiovascular surgery. 2. All pregnant women with Obstructive Lung diseases The purpose of the study was explained to the patients and collected inform consent from them. A suitably designed Case Record Form was prepared and used to record all the necessary and relevant data from the medical records of patients which mainly included admission sheets, patient history notes, patient treatment charts, laboratory data reports, progress sheets, prescriptions, doctor s orders. We asked different queries to patients/ representatives regarding their present complaints, and addictive habits which were not available in their case sheets. The treatment details were recorded from their case sheets RESULTS This study was conducted in General Medicine Department of Mandya Institute of Medical Science Teaching Hospital, Mandya. A total of 250 COPD patients admitted in Mandya Institute of Medical Science teaching hospital were enrolled in the study based on study criteria. The required details from the patient case sheet were recorded in a suitably designed case report form. The patients were categorised on the basis of age, gender, social history and disease condition. Among 250 COPD cases, there were 64 patients who were having only COPD and 186 patients with co-morbid conditions. (Table 1).
3 Page6260 Table 1: Demographic Parameters. DEMOGRAPHIC PARAMETERS Mean Age+ SD Smoking history Smokers Non smokers Ex-smokers Alcoholic History Alcoholic Non-Alcoholic Ex Alcoholic Disease condition COPD COPD Infective exacerbation COPD + Corpulmonale COPD + Multiple Disease 52% 44% 3.2% 16% 83% 0.8% 25.6% 04.8% 12.8% 56.8% PATIENT DISTRIBUTION BASED ON AGE AND GENDER The prescription data of 250 patients were analysed in the current study, out of which 188 were males (75.2%) and 62 were females (24.8%). The mean age of all patients was found to be years being and years in male and female respectively. The male to female ratio was found to be 3.03 from the study. (Table 2, Fig. 1) Table 2: Patient Distribution based on Age and Gender. Gender No. Of Patients, N (%) Mean Age+ SD (Years) Total Male 188 (75.2%) Female 62 (24.8 %) Fig 1: Patient Distribution based on Gender. PATIENT DISTRIBUTION BASED ON SOCIAL HISTORY We divided 250 patients based on their addictive habits such as smoking and alcoholism. 130 patients (52%) were found to be smokers and 40 were alcoholics (16%). 110 patients were non-smokers (44%) and 208 were non-alcoholics (83%). 10 were exsmokers (4%) and 2 was ex-alcoholic (0.8%). (Table 3, Fig 2)
4 Page6261 Table 3: Patient Distribution Based On Social History. SMOKING HISTORY SMOKERS NON- SMOKERS (52%) (44%) EX- SMOKERS 10 (4%) ALCOHOLISM ALCOHOLIC NON- ALCOHOLIC (16%) (83%) EX- ALCOHOLIC 02 (0.8%) Figure 2: Patient Distribution Based On Social History. COMMONLY PRESCRIBED DRUGS BY CLASS Among 250 prescriptions, it has been seen that all the prescriptions contained more than 3 drugs. The prescription of more than 3 drugs for one patient may be attributed to the possibility of some patients presenting with acute and chronic exacerbation of COPD with or without co-morbid conditions, which requires antibiotic and corticosteroid treatment. In COPD the class of drugs observed, antibiotics were mostly prescribed (19.2%), followed by anticholinergics (18.70%), Short acting beta-2 agonists (18.10%), inhaled corticosteroids (17.20%), Methylxanthines (15.50%), systemic corticosteroids (6.90%), Long acting beta-2 agonist (4.10% )and secretolytic agents (0.30%). (Fig 3). Figure 3: Percentage of Drugs Prescribed by Class. PATIENT DISTRIBUTION BASED ON MONOTHERAPY Out of 250 prescriptions, Deriphylline was the drug which was given for majority of patients as single drug (71.20%), followed by Budesonide (64.80%), Ceftriaxone (56%), Cefotaxim (34%), Hydrocortisone (24%), Dexamethasone (22.40%), CPM (13.60%), Salbutamol (12%), Aminophylline (9.60%), Levofloxacin (6%), and Azithromycin (4%). (Table 4, Fig 4)
5 Page6262 Table 4: Percentage of Drugs Prescribed As Monotherapy. DRUG PERCENTAGE Deriphylline 71.20% Ceftriaxone 56% Cefotaxim 34% Levofloxacin 6% Azithromycin 4% Dexamathasone 22.40% Hydrocortisone 24% Budesonide 64.80% Aminophylline 9.60% CPM 13.60% Salbutamol 12% Figure 4: Percentage of Drugs Prescribed As Monotherapy. PATIENT DISTRIBUTION BASED ON FIXED DOSE COMBINATION Majority of the patients were prescribed with combination therapy. Salbutamol sulphate + Ipratropium Bromide (23.19%), Salbutamol sulphate + Ipratropium Bromide + Budesonide (42.23%), Budesonise + Formeterol (5.90%), Etophylline + Theophylline (19.47%), Dextromethorphen + HBr + Phenylephrine + Cpm + Menthol (0.87%), Bromhexine + Guaiphenesin + Terbutaline + Menthol (4.15%), Beclomethasone + Levosalbutamol (0.21%), Ambroxol + Levosalbutamol (0.87%), Theophylline + Ethylenediamine (2.61%) were the drugs prescribed in combination. (Fig 5). Figure 5: Percentage Of Drug Used as Combination Therapy. PATIENT DISTRIBUTION BASED ON ROUTE OF ADMINISTRAION Our study also revealed that inhalation route (38.32%) was more preferred over parenteral (37.98%) and oral route (23.70%). (Table 5, Fig 6)
6 Page6263 Table 5: Percentage of Drugs Prescribed in Different Dosage Forms. DOSAGE FORMS PERCENTAGE ORAL % PARENTERAL % INHALATION % Figure 6: Percentage of Drugs Prescribed in Different Dosage Form. DISCUSSION A lot of population are suffering from these chronic respiratory diseases. Hence it became very essential to spread a thorough awareness among patients in relation to medication and disease itself. So evaluation of drug utilisation pattern in asthma and COPD will provide a powerful tool in order to find depth of awareness in patients and physician.a prescription based study is considered one of the scientific methods to evaluate the rationality of the prescription. Drug utilization research is an essential part of pharmacoepidemiology as it describes the extent, nature and determinants of drug exposure. Drug use is a complex process. In any country a large number of socio-cultural factors contribute to the ways drugs [10]. A total of 250 patients were analysed in our study. Out of that 188 were males and 62 were females.the patients were categorised according to their age and gender. The age group being kept at interval of 10 years. The maximum numbers of male patients are found in range of years and minimum numbers of patients are found in year age group. Whereas for female, maximum number of patients are in years age group and minimum in years. The risk of COPD was found more in elderly than in younger patients. Globally, COPD by 2020 is expected to rise to the 3rd position as a cause of death and at 5th position as the cause of loss of disabilityadjusted life years (DALYs) according to the baseline projections made in the Global Burden of Disease Study (GBDS). The largest increase in the tobacco related mortality is estimated to occur in India, China and other Asian countries [11]. The patients were categorised on the basis of their Social history, disease conditions.250 patients were categorised based on their addictive habits such as Smoking and Alcoholism. 130 patients (52%) were found to be smokers and 40 were alcoholics (16%).110 patients were non-smokers (44%) and 208 were non-alcoholics (83%). 10 were ex-smokers (3.2%) and 2 was ex-alcoholic (0.8%). Among 250 prescriptions, it has been seen that all the prescriptions contained more than 3 drugs. The prescription of more than 3 drugs for one patient may be attributed to the possibility of some patients presenting with acute and chronic exacerbation of COPD with or without co-morbid conditions, which requires antibiotic and corticosteroid treatment. Antibiotics were mostly prescribed (19.2%), followed by anticholinergics(18.70%), Short acting beta-2 agonists (18.10%), inhaled corticosteroids(17.20%), Methylxanthines(15.50%), systemic corticosteroids (6.90%), Long acting beta-2 agonist(4.10% )and secretolytic agents(0.30%).deriphylline was the drug which was given for majority of patients as single drug (71.20%). Our study also revealed that inhalation route (38.32%) was more preferred over parenteral (37.98%) and oral route (23.70%). CONCLUSION In our study, we observed that the incidence of COPD was more common in males when compared to females. Majority of the patients were from the age group of years. Obstructive Lung diseases are more prominent in smokers when compared to non-smokers. Most of the patients were prescribed with multiple drug therapy out of which inhalation route was the most preferred one. The inhalation route to lungs causes a high local concentration in the lungs with a low systemic delivery, significantly improves the therapeutic effectiveness and minimizes the systemic side effect. Even though Methyl xanthine was the most commonly prescribed class of drug for monotherapy, they could have been avoided due to their adverse effects and instead could have used other safe antiasthmatics which are available.
7 Page6264 Our study has some potential limitations. First, due to the limited time duration, we were unable to carry out this study in large population. Second, certain data were obtained using medical record review and some of the quality deficit may be due to under-documentation. This study recommend for the further study to identify drug interaction and poly pharmacy. From our study, we found that the total control of COPD was not achieved. The majority of patients had intermittent exacerbations of COPD. The pattern of drug use is inadequate. GOLD guidelines can be properly followed for prescribing drugs for COPD and can be achieve total control of COPD. ACKNOWLEDGEMENT We thank to IEC of MIMS teaching hospital for giving approval to conduct this study. We are also grateful to the faculty of General Medicine for extending all their help to us during this study. List of abbreviation CRD -Chronic Respiratory Disease COPD -Chronic Obstructive Pulmonary disease DUR -Drug Utilisation Review DUE -Drug Utilization Evaluation REFERENCE 1. Joan B, Soriano, Roberto Rodriguez-Roisin. Chronic obstructive pulmonary disease overview epidemiology, risk factors, and clinical presentation. Proc Am Thorac Soc. 2011; 8: V.K. Vijayan. Chronic obstructive pulmonary disease; Indian J Med Res.2013; 137: R. D. Shimpi, P. S. Salunkhe, S. R. Bavaskar, G. P. Laddha, A. Kalam, A. Khalik Patel. Drug utilization evaluation and prescription monitoring in asthmatic patients. Int. J. Pharm. Biol. Sci.2012; 2(1): Sharon Sunil, Arya Gigi, Prince Hepzhiba, Dr. Mahesh N. M, MrudulaGiri, Dr.Ajoy Krishnamurthy. Drug utilization evaluation in chronic obstructive pulmonary disease patients - A prospective study. World J Pharm Sci.201;5(1): Pushpender Sharma, B. Kapoor. Study of prescribing pattern for rational drug therapy; from the Department of Pharmacology, Government medical college, Jammu (J&K) India.2003;5(3): AswathyUnni, Akshaya K Jayaprakash, Yadukrishnan MC, Uma Devi P. Drug utilization pattern in chronic obstructive pulmonary disease inpatient at a tertiary care hospital. Int J Pharm Sci.2015;7(11): G. Viegi, F. Pistelli, D.L. Sherrill, S. Maio, S. Baldacci, L. Carrozzi. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;30: World Health Organization Global Initiative for Chronic Obstructive Lung Disease, Pocket Guide to COPD Diagnosis, Management and Prevention. Available from 9. AleemuddinNM, Farahbahmed, Mohammed Shakeel Mohammed Bashir, Aamir Ali, Salma Khatoon, MdMohib Hussain, AfshanKhatoon. A cross-sectional study on prescribing patterns on patients suffering from respiratory disorders in a teaching hospital of south India. J Cont Med A Dent. 2014; 2(1): Sachdeva,P.D., and Patel,B.G. Drug utilization studies- scope and future perspectives. IJPBR 2010:1(1) Hurd S. The impact of COPD in lung health worldwide: Epidemiology and incidence. Chest 2000; 117: 1S-4S
Assessment of prescribing patterns of drugs used in adult asthma patients at a tertiary care hospital.
International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Original Research Article Volume 3, Issue 6-2017 Assessment of prescribing
More informationAssessment of Prescribing Pattern of Drugs in the Management of Obstructive Lung Diseases and Respiratory Tract Infections
Page1 Int J Pharm Pharmacol 2017; 1(4): 117 Available at http://ijpp.edwiserinternational.com/home.php Research Article International Journal of Pharmaceutics & Pharmacology Assessment of Prescribing Pattern
More informationDRUG UTILIZATION EVALUATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2017, 9 [6]:142-151 [http://scholarsresearchlibrary.com/archive.html] ISSN 0975-5071 USA CODEN: DPLEB4
More informationA Study of Prescription Pattern in the Management of COPD in a Tertiary Care Hospital.
DOI: 10.21276/aimdr.2016.2.3.39 Original Article ISSN (O):2395-2822; ISSN (P):2395-2814 A Study of Prescription Pattern in the Management of COPD in a Tertiary Care Hospital. Mazher Maqusood 1, Farhan
More informationGlobal Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health
Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline MedStar Health These guidelines are provided to assist physicians and other clinicians in making decisions
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
DRAFT NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary
More informationJMSCR Vol 05 Issue 04 Page April 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i4.28 Adverse Drug Reaction Monitoring in Chronic
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary
More information2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters
GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationDrug prescriptions (Pharm) Exposure (36/48 months)
ANNEX SECTION PART A - Study design: Figure 1 overview of the study design Drug prescriptions (Pharm) 2006-2010 Exposure (36/48 months) flexible time windows (e.g. 90 days) time index date (hospital discharge)
More informationCOPD in primary care: reminder and update
COPD in primary care: reminder and update Managing COPD continues to be a major feature of primary care, particularly in practices with a high proportion of M ori and Pacific peoples. COPDX clinical practice
More informationCARE OF THE ADULT COPD PATIENT
CARE OF THE ADULT COPD PATIENT Target Audience: The target audience for this clinical guideline is all MultiCare providers and staff including those associated with our Clinically Integrated Network. The
More informationAnnamalai Nagar, Tamil Nadu India. Corresponding Author: Riya Teresa Joseph
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn:2278-3008, p-issn:2319-7676. Volume 12, Issue 4 Ver. IV (Jul Aug 2017), PP 01-07 www.iosrjournals.org Study of Nebulization with Hypertonic
More informationEVALUATION OF BETA BLOCKERS USE AT A TERTIARY CARE HOSPITAL
Page2587 Indo American Journal of Pharmaceutical Research, 2015 ISSN NO: 2231-6876 EVALUATION OF BETA BLOCKERS USE AT A TERTIARY CARE HOSPITAL Sukesh Krishna Chaitanya Loka *, Vinuthna Yashki, Alekhya
More informationGuideline for the Diagnosis and Management of COPD
Guideline for the Diagnosis and Management of COPD Introduction Chronic obstructive pulmonary disease (COPD) is a respiratory disorder largely caused by smoking. It is characterized by progressive, partially
More information7.2 Part VI.2 Elements for a Public Summary
7.2 Part VI.2 Elements for a Public Summary 7.2.1 Part VI.2.1 Overview of disease epidemiology Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation that is usually
More informationDRUG UTILIZATION EVALUATION OF BRONCHIAL ASTHMA IN TERTIARY CARE HOSPITAL
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Michael et al. SJIF Impact Factor 5.210 Volume 5, Issue 2, 1075-1091 Research Article ISSN 2278 4357 DRUG UTILIZATION EVALUATION OF BRONCHIAL ASTHMA
More informationDRUG UTILIZATION STUDIES TO GUIDE BETTER HOSPITAL PHARMACEUTICAL POLICY
DRUG UTILIZATION STUDIES TO GUIDE BETTER HOSPITAL PHARMACEUTICAL POLICY Dr. G. Parthasarathi Professor, Pharmacy Practice JSS University, Mysore 30 October 2011 ACPE6 Beijing, 2011 1 Presentation Outline
More informationDecramer 2014 a &b [21]
Buhl 2015 [19] Celli 2014 [20] Decramer 2014 a &b [21] D Urzo 2014 [22] Maleki-Yazdi 2014 [23] Inclusion criteria: Diagnosis of chronic obstructive pulmonary disease; 40 years of age or older; Relatively
More informationeducating people and transforming lives worldwide
Takingaction, educating people and transforming lives worldwide COPD elearning Diploma (Level 5) Module 2012 CONTENTS PAGE UNIT 1: WRITING FOR SUCCESS Writing for Success 2 UNIT 2: INTRODUCTION TO COPD
More information2017 GOLD Report. Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017
2017 GOLD Report Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017 Lauren Munro; BSc(Pharm) Amanda Burns; BSc(Pharm) Pharmacy Residents The Moncton Hospital Objectives Explain
More information2014 Physician Quality Reporting System Data Collection Form: Asthma (for patients aged 5-64)
2014 Physician Quality Reporting System Data Collection Form: Asthma (for patients aged 5-64) Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy Gender: M F Patient Insured - Traditional
More informationOn completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
More informationROLE OF CLINICAL PHARMACIST IN IMPACT OF PATIENT COUNSELLING IN ASTHMATIC PATIENTS
Research Article ROLE OF CLINICAL PHARMACIST IN IMPACT OF PATIENT COUNSELLING IN ASTHMATIC PATIENTS Rathan Shyam M* 1, Jyothi D 1, T. S. Durga Prasad 1 Venkata Subbaiah M 1 Ravindra Reddy K 1 Dr. S. Chandra
More informationChronic obstructive pulmonary disease
0 Chronic obstructive pulmonary disease Implementing NICE guidance June 2010 NICE clinical guideline 101 What this presentation covers Background Scope Key priorities for implementation Discussion Find
More informationIJBCP International Journal of Basic & Clinical Pharmacology
Print ISSN: 2319-2003 Online ISSN: 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20162852 Research Article Prescription audit and
More informationA Study on Drug Prescribing Pattern in Upper Respiratory Tract Infections among Pediatrics in Tertiary Care Hospital, Palakkad
Human Journals Research Article June 2016 Vol.:6, Issue:3 All rights are reserved by Resmi.T.M et al. A Study on Drug Prescribing Pattern in Upper Respiratory Tract Infections among Pediatrics in Tertiary
More informationTreatment. Assessing the outcome of interventions Traditionally, the effects of interventions have been assessed by measuring changes in the FEV 1
58 COPD 59 The treatment of COPD includes drug therapy, surgery, exercise and counselling/psychological support. When managing COPD patients, it is particularly important to evaluate the social and family
More informationCommissioning for Better Outcomes in COPD
Commissioning for Better Outcomes in COPD Dr Matt Kearney Primary Care & Public Health Advisor Respiratory Programme, Department of Health General Practitioner, Runcorn November 2011 What are the Commissioning
More informationTHE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable
THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc. COPD in the United States Third leading cause
More informationBetter Living with Obstructive Pulmonary Disease A Patient Guide
Better Living with Obstructive Pulmonary Disease A Patient Guide Second Edition November 2012 Queensland Health a Better Living with Chronic Obstructive Pulmonary Disease A Patient Guide is a joint project
More informationBreaking Down Barriers to Pulmonary Therapies: Patient Education, Teach Back, and More
Breaking Down Barriers to Pulmonary Therapies: Patient Education, Teach Back, and More Char Raley, RRT Brandon Johnson, PharmD, BCPS Pulmonary and Critical Care Symposium June 12 th, 2015 We have had no
More informationWhat s New in Acute COPD? Dr Nick Scriven Consultant AIM President SAM
What s New in Acute COPD? Dr Nick Scriven Consultant AIM President SAM Covering: Basic Definition New assessment criteria Some newer treatments BiPAP Not Covering: Definitions: Chronic Obstructive Pulmonary
More informationAt-A-Glance Outpatient Management Reference for Chronic Obstructive Pulmonary Disease (COPD)
At-A-Glance Outpatient Management Reference f Chronic Obstructive Pulmonary Disease (COPD) BASED ON THE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT AND PREVENTION OF COPD GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE
More information«Impact of a pharmaceutical intervention to improve adherence of inhaled medication in asthma and COPD patients»
«Impact of a pharmaceutical intervention to improve adherence of inhaled medication in asthma and COPD patients» Baseline data from a randomized controlled trial 5 th Swiss Health Services Research Symposium,
More informationInternational Journal of Advancements in Research & Technology, Volume 2, Issue 6, June-2013 ISSN
ISSN 2278-7763 295 Study of Prescriptive Patterns of Antihypertensive Drugs in South India Popuri Rupa Sindhu, Malladi Srinivas Reddy St. Peters Institute of Pharmaceutical Sciences, Hanamkonda, Warangal-506001,
More informationOpioid use in COPD: balancing benefits and harms. St. Michael s Hospital, University of Toronto
Opioid use in COPD: balancing benefits and harms Nicholas Vozoris MHSc, MD, FRCPC Assistant Professor St. Michael s Hospital, University of Toronto Conflicts of interest None None of my own drug safety
More informationDefining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist
Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease
More informationCME/CE QUIZ CME/CE QUESTIONS
CME/CE QUIZ CME/CE QUESTIONS Continuing Medical Education Accreditation The University of Cincinnati College of Medicine designates this educational activity for a maximum of 2 Category 1 credits toward
More informationChitra C. Nair et al. Int. Res. J. Pharm. 2014, 5 (5) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article EVALUATION OF THE KNOWLEDGE OF PATIENTS, COMPLIANCE TO TREATMENT AND THE IMPACT OF PATIENT EDUCATION ON ASTHMA:
More informationA preliminary assessment of nurses asthma education needs and the effect of a training. programme in an urban tertiary healthcare facility.
A preliminary assessment of nurses asthma education needs and the effect of a training programme in an urban tertiary healthcare facility O O Adeyeye, Y A Kuyinu, R T Bamisile, and C I Oghama Abstract
More informationUsers of antiasthma drugs in Iceland: a drug utilization study
Eur Respir J 1997; 10: 1230 1234 DOI: 10.1183/09031936.97.10061230 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 Users of antiasthma drugs
More informationDesign - Multicentre prospective cohort study. Setting UK Community Pharmacies within one CCG area within the UK
Enabling Patient Health Improvements through COPD (EPIC) Medicines Optimisation within Community Pharmacy: a prospective cohort study Abstract Objectives To improve patients ability to manage their own
More informationUNDERSTANDING COPD MEDIA BACKGROUNDER
UNDERSTANDING COPD MEDIA BACKGROUNDER What is COPD? Chronic Obstructive Pulmonary Disease (COPD) also called emphysema and/or chronic obstructive bronchitis* is a preventable lung disease caused by the
More informationKeywords: Prescribing pattern, Osteoarthritis, Rheumatoid arthritis
Human Journals Research Article May 2016 Vol.:6, Issue:2 All rights are reserved by Anjali.C et al. A Prospective Observational Study to Assess Prescription Pattern in Osteoarthritis & Rheumatoid Arthritis
More informationTo Study the Prescribing Pattern of Respiratory Distress Associated with Wheezing in Pediatric Patients
To Study the Prescribing Pattern of Respiratory Distress Associated with Wheezing in Pediatric Patients Jocy Mathew 1, Dr. R. Ramanathan 2 1 Pharm D. [Intern], Department of Pharmacy, Annamalai University,
More informationAssessment of Medication-Related Problems in Geriatric Patients of a Rural Tertiary Care Hospital
Pharmacy Practice Assessment of Medication-Related Problems in Geriatric Patients of a Rural Tertiary Care Hospital Ramanath KV, Nedumballi S Department of Pharmacy Practice, Sri Adichunchanagiri College
More informationSummary of the risk management plan (RMP) for Duaklir Genuair (aclidinium / formoterol fumarate dihydrate)
EMA/605453/2014 Summary of the risk management plan (RMP) for Duaklir Genuair (aclidinium / formoterol fumarate dihydrate) This is a summary of the risk management plan (RMP) for Duaklir Genuair, which
More informationInternational Journal of Pharmaceutical and Medicinal Research
Int. J. Pharm. Med. Res. 2014; 2(2):43-48 ISSN: 2347-7008 International Journal of Pharmaceutical and Medicinal Research Journal homepage: www.ijpmr.org Research article Prescription Monitoring of drugs
More informationNational COPD Audit Programme
National COPD Audit Programme Planning for every breath National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: Primary care audit () 2015 17 Data analysis and methodology Section 4: Providing
More informationHow to treat COPD? What is the mechanism of dyspnea? Smoking cessation
: The Increasing Role of the FP Alan Kaplan, MD, CCFP(EM) Presented at the Primary Care Today: Education Conference and Medical Exposition, Toronto, Ontario, May 2006. Chronic obstructive pulmonary disease
More informationGlobal Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health
Global Strategy f the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline MedStar Health These guidelines are provided to assist physicians and other clinicians in making decisions
More informationAECOPD: Management and Prevention
Neil MacIntyre MD Duke University Medical Center Durham NC Professor P.J. Barnes, MD, National Heart and Lung Institute, London UK Professor Peter J. Barnes, MD National Heart and Lung Institute, London
More informationCOPD Update. Plus New and Improved Products for Inhaled Therapy. Catherine Bourg Rebitch, PharmD, BCACP Clinical Associate Professor
COPD Update Plus New and Improved Products for Inhaled Therapy Catherine Bourg Rebitch, PharmD, BCACP Clinical Associate Professor Disclosure The presenter has nothing to disclose concerning possible financial
More informationSummary of the risk management plan (RMP) for Budesonide/Formoterol Teva (budesonide / formoterol)
EMA/639304/2014 Summary of the risk management plan (RMP) for Budesonide/Formoterol Teva (budesonide / formoterol) This is a summary of the risk management plan (RMP) for Budesonide/Formoterol Teva, which
More informationIJBCP International Journal of Basic & Clinical Pharmacology
Print ISSN: 2319-2003 Online ISSN: 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology doi: 10.5455/2319-2003.ijbcp003812 Research Article Prescription auditing and drug utilization
More informationCOPD. Breathing Made Easier
COPD Breathing Made Easier Catherine E. Cooke, PharmD, BCPS, PAHM Independent Consultant, PosiHleath Clinical Associate Professor, University of Maryland School of Pharmacy This program has been brought
More informationAsthma - Chronic. Presentations of asthma Cough Wheeze Breathlessness Chest tightness
Asthma - Chronic Definition of asthma Chronic inflammatory disease of the airways 3 components: o Reversible and variable airflow obstruction o Airway hyper-responsiveness to stimuli o Inflammation of
More informationCHARM ASTHMA TREATMENT GUIDELINE
NHS City and Hackney Prescribing Guidelines Adults ( 12 years of age) CHARM ASTHMA TREATMENT GUIDELINE Written by: Hetal Dhruve (Specialist Respiratory Pharmacist, City and Hackney CCG) Checked by: Prof
More informationNational COPD Audit Programme
National COPD Audit Programme Planning for every breath Primary Care Audit (Wales) 2015-17 Findings and quality improvement The audit programme partnership Working in strategic partnership: Supported by:
More informationLead team presentation: Roflumilast for treating chronic obstructive pulmonary disease [ID984]
Lead team presentation: Roflumilast for treating chronic obstructive pulmonary disease [ID984] 1 st Appraisal Committee meeting Background & Clinical Effectiveness John McMurray 11 th January 2016 For
More informationOpen Access. A Prospective Study on Medication Prescribing Pattern for Geriatric Patients in a Tertiary Care Teaching Hospital
A Prospective Study on Medication Prescribing Pattern for Geriatric Patients in a Tertiary Care Teaching Hospital Research Article Article Info: Received on: 02/05/2016 Published on:31/05/2016 QR Code
More informationMULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient
Clinical Guideline Ver. 2.0 MULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient Target Audience: The target audience for this clinical guideline is all MHS providers
More informationSummary of the risk management plan (RMP) for Vylaer Spiromax (budesonide / formoterol)
EMA/675937/2014 Summary of the risk management plan (RMP) for Vylaer Spiromax (budesonide / formoterol) This is a summary of the risk management plan (RMP) for Vylaer Spiromax, which details the measures
More informationSummary of the risk management plan (RMP) for DuoResp Spiromax (budesonide / formoterol)
EMA/126654/2014 Summary of the risk management plan (RMP) for DuoResp Spiromax (budesonide / formoterol) This is a summary of the risk management plan (RMP) for DuoResp Spiromax, which details the measures
More informationPage 126. Type of Publication: Original Research Paper. Corresponding Author: Dr. Rajesh V., Volume 3 Issue - 4, Page No
ISSN- O: 2458-868X, ISSN P: 2458 8687 Index Copernicus Value: 49. 23 PubMed - National Library of Medicine - ID: 101731606 SJIF Impact Factor: 4.956 International Journal of Medical Science and Innovative
More informationCurrent Scenario on Drugs Utilized for Treatment and Management of Asthma
Human Journals Research Article September 2018 Vol.:13, Issue:2 All rights are reserved by Chanchal Chaurasiya et al. Current Scenario on Drugs Utilized for Treatment and Management of Asthma Keywords:
More informationDiagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma
Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Magnitude of Asthma - India Delhi Childhood asthma: 10.9% Adults: 8% Other Cities 3 to 18% Chhabra SK et al Ann Allergy Asthma
More informationinformation Chronic Obstructive Pulmonary Disease - COPD (1 of 5) What is COPD? What is going on in my lungs? What are the symptoms of COPD?
information If you need this information in another language or medium (audio, large print, etc) please contact the Patient Advice and Liaison Service (PALS) on 0800 374 208 email: pal.service@ salisbury.nhs.uk.
More informationChronic Obstructive Pulmonary Disease
Page 1 of 5 Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease (COPD) is an 'umbrella' term for people with chronic bronchitis, emphysema, or both. With COPD the airflow to the
More informationStep-down approach in chronic stable asthma: A comparison of reducing dose Inhaled Formoterol/ Budesonide with maintaining Inhaled Budesonide.
Step-down approach in chronic stable asthma: A comparison of reducing dose Inhaled Formoterol/ Budesonide with maintaining Inhaled Budesonide. By: DR MOHD SHAMSUL AMRI Supervisor: Associate Professor Dr
More informationCOPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis.
1 Definition of COPD: COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis. Airflow obstruction may be accompanied by airway hyper-responsiveness
More informationSummary of the risk management plan (RMP) for Laventair (umeclidinium bromide and vilanterol)
EMA/258177/2014 Summary of the risk management plan (RMP) for Laventair (umeclidinium bromide and vilanterol) This is a summary of the risk management plan (RMP) for Laventair, which details the measures
More informationDudhe et al: Rational use of medicine
ORIGINAL ARTICLE Evaluation of Knowledge, Attitude, Practice of Rational use of Medicine among Residents in a Tertiary Care Hospital of Central India Dudhe BG 1, Mahajan HM 2, Badwaik RT 3, Bhosale RA
More informationInt. J. Adv. Multidiscip. Res. (2016). 3(6):
International Journal of Advanced Multidisciplinary Research (IJAMR) ISSN: 2393-8870 www.ijarm.com Volume 3, Issue 6-2016 Research Article A prospective study on prescribing pattern of pulmonary inhalers
More informationPrudhivi Ramakrishna et al / Int. J. Res. Ayurveda Pharm. 7(Suppl 4), Sep Oct Research Article.
Research Article www.ijrap.net MONITORING OF PRESCRIPTION PATTERN OF ANTIMICROBIAL AGENTS IN MEDICINE DEPARTMENT OF A TERTIARY CARE HOSPITAL Prudhivi Ramakrishna * 1, Maddi Ramaiah 2, Krishna Pavan Kumar
More informationManaging Exacerbations of COPD (Version 3.0)
Managing Exacerbations of COPD (Version 3.0) Guideline Readership This guideline is intended for use in patients with a confirmed diagnosis of a chronic obstructive pulmonary disease (COPD) exacerbation.
More informationChronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD) Scope: The guideline provides strategies for the improved diagnosis and management of adults with chronic bronchitis and emphysema (chronic obstructive pulmonary
More informationASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides
BRONCHIAL ASTHMA ASTHMA Epidemiology Pathophysiology Diagnosis 2 CHILDHOOD ASTHMA Childhood bronchial asthma is characterized by Airway obstruction which is reversible Airway inflammation Airway hyper
More informationExacerbations of COPD. Dr J Cullen
Exacerbations of COPD Dr J Cullen Definition An AECOPD is a sustained worsening of the patient s clinical condition from their stable state that is beyond their usual day-to-day variation is acute in onset
More informationChronic obstructive pulmonary disease
Chronic obstructive pulmonary disease Abstract Whittaker C, BPharm, MRPharmS Amayeza Info Centre Chronic obstructive pulmonary disease affects millions of people, has a major impact on quality of life
More informationCOPD: Current Medical Therapy
COPD: Current Medical Therapy Angela Golden, DNP, FNP-C, FAANP Owner, NP from Home, LLC Outcomes As a result of this activity, learners will be able to: 1. List the appropriate classes of medications for
More informationPrevalence of Polypharmacy in Geriatric Patients in Rural Teaching Hospital
Original Article Prevalence of Polypharmacy in Geriatric Patients in Rural Teaching Hospital Maheshkumar V.P.* and Dhanapal C.K Department of Pharmacy, Annamalai University, Chidambaram- 608002, Tamil
More informationASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp ASTHMA CARE FOR CHILDREN
More informationBackground. Background. Background 3/14/2014. Conflict of Interest Statement:
Platform Presentations Comparison of zolpidem to other drugs associated with falls in hospitalized patients Ed Rainville, MSPharm. Conflict of Interest Statement: The speaker has no conflict of interest
More informationPatient Education at the Point of Dispensing Improves Adherence and Increases Sales
Patient Education at the Point of Dispensing Improves Adherence and Increases Sales A COPD study in Germany Reach. Connect. Understand. Executive summary Introduction More than half of patients with chronic
More informationRajiv Gandhi University of Health Sciences
ISSN 2310-4090 Prescribing Patterns and Health Related Quality of Life in Patients with Diabetes Mellitus in a Tertiary Care Hospital in South India: A Research Article Venkataraman, R. 1,Rao, A. 2,Deepak,
More informationThe clinical quality measures as selected by the Clinical Management subcommittee for 2016 for the adult population are:
For 2016 the Clinical Integration Program is moving its clinical quality measures from the Verisk Healthcare Quality and Risk Measures to the National Committee for Quality Assurance HEDIS based measures.
More informationDisclosures. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease May 14, 2016 Orlando, FL COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United States. Alarmingly, COPD recently became
More informationIn 2002, it was reported that 72 of 1000
REPORTS Aligning Patient Care and Asthma Treatment Guidelines Eric Cannon, PharmD Abstract This article describes how the National Asthma Education and Prevention Program Guidelines for the Diagnosis and
More informationStudy of Prescribing Pattern and Impact of Pharmaceutical Care in Bronchial Asthmatic Paediatric Patients in a Tertiary Care Teaching Hospital
Study of Prescribing Pattern and Impact of Pharmaceutical Care in Bronchial Asthmatic Paediatric Patients in a Tertiary Care Teaching Hospital Research Article Vengala Bhavan Kumar *1, Tina Mariam Thankachan
More informationDisclosure Statement. Epidemiological Data
EVALUATION OF THE MEDICATION UTILIZATION OF COPD PATIENTS AT THE MIAMI VA HEALTHCARE SYSTEM Simone Edgerton, PharmD. PGY 1 Pharmacy Resident Miami VA Healthcare System Miami, Florida Simone.edgerton2@va.gov
More informationSTUDY ON PRESCRIBING AND ADMINISTRATION OF THERAPEUTIC AEROSOLS IN PEDIATRIC PULMONARY DISEASE AT A PRIVATE TERTIARY CARE TEACHING HOSPITAL
Page455 IJPBS Volume 3 Issue 3 JUL-SEP 2013 455-461 Research Article Pharmaceutical Sciences STUDY ON PRESCRIBING AND ADMINISTRATION OF THERAPEUTIC AEROSOLS IN PEDIATRIC PULMONARY DISEASE AT A PRIVATE
More informationOPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING 10/16/2018 DISCLOSURES I have no financial or other disclosures
OPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING J. Michael Fuller, MD, MEd, FACP, FCCP Associate Professor of Medicine University of South Carolina Greenville DISCLOSURES I have no financial or other
More informationAssessment of Incidence, Clinical Profile, Risk Factors and Drug Utilization Pattern in the Management of Gastroenteritis
Page1 Int J Pharm Pharmacol 2017; 1(3): 113 Available at http://ijpp.edwiserinternational.com/home.php Research Article International Journal of Pharmaceutics & Pharmacology Assessment of Incidence, Clinical
More informationRESPIRATORY CARE IN GENERAL PRACTICE
RESPIRATORY CARE IN GENERAL PRACTICE Definitions of Asthma and COPD Asthma is due to inflammation of the air passages in the lungs and affects the sensitivity of the nerve endings in the airways so they
More informationCHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE INCIDENCE UP TO 380,000 PEOPLE IN IRELAND HSE FIGURES 110,000 DIAGNOSED AND 200,000 UNDIAGNOSED. AFFECTS MORE MEN THAN WOMEN BUT RATES ARE RISING 1500 DEATHS PER YEAR
More information2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members
2012 Chronic Respiratory Program Evaluation Our mission is to improve the health and quality of life of our members 2012 Chronic Respiratory Program Evaluation Program Title: Chronic Respiratory Program
More information